Most sold healthcare stocks in Q1 2024
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2024, measured as net reductions in reported share positions from Q4 2023 into Q1 2024. Notable reductions at the top of this list include GILEAD SCIENCES INC (GILD), TEVA PHARMACEUTICAL-SP ADR (TEVA), TELADOC HEALTH INC (TDOC), VIKING THERAPEUTICS INC (VKTX). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | -11,942,540 | -$1.16B | 1 | 3 | 11 | 2 | 15 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -5,494,440 | -$51.36M | 1 | 2 | 4 | 2 | 7 |
| TDOC | TELADOC HEALTH INC | -4,556,011 | -$217.34M | 1 | 3 | 2 | 1 | 6 |
| VKTX | VIKING THERAPEUTICS INC | -4,023,622 | -$3.78M | 2 | 1 | 1 | 0 | 4 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -3,168,966 | $220.41M | 2 | 3 | 4 | 0 | 12 |
| VTRS | VIATRIS INC | -2,904,778 | -$29.01M | 2 | 0 | 6 | 2 | 9 |
| EWTX | EDGEWISE THERAPEUTICS INC | -2,839,300 | -$6.47M | 0 | 0 | 2 | 0 | 2 |
| QSI | QUANTUM-SI INC | -2,750,746 | -$6.04M | 0 | 0 | 2 | 0 | 2 |
| EXAS | EXACT SCIENCES CORP | -2,639,809 | -$214.85M | 1 | 3 | 2 | 2 | 6 |
| PFE | PFIZER INC | -2,544,433 | -$43.06M | 2 | 8 | 10 | 4 | 23 |
| HOLX | HOLOGIC INC | -2,365,999 | -$61.79M | 1 | 3 | 4 | 0 | 9 |
| AMLX | AMYLYX PHARMACEUTICALS INC | -2,329,243 | -$43.61M | 0 | 1 | 0 | 1 | 1 |
| BFLY | BUTTERFLY NETWORK INC | -2,254,086 | -$2.62M | 0 | 1 | 3 | 0 | 4 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -2,192,634 | -$79.54M | 1 | 0 | 1 | 0 | 3 |
| WRBY | WARBY PARKER INC-CLASS A | -2,087,132 | -$34.26M | 0 | 1 | 2 | 0 | 3 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | -1,783,167 | -$3.49M | 1 | 0 | 1 | 0 | 2 |
| RCM | R1 RCM INC | -1,760,800 | -$18.52K | 0 | 0 | 1 | 0 | 1 |
| DHR | DANAHER CORP | -1,746,386 | -$46.31M | 2 | 3 | 8 | 3 | 20 |
| CDNA | CAREDX INC | -1,394,276 | -$27.17M | 0 | 1 | 2 | 0 | 3 |
| THC | TENET HEALTHCARE CORP | -1,311,259 | -$93.91M | 3 | 0 | 2 | 1 | 5 |
| COYA | COYA THERAPEUTICS INC | -1,274,026 | -$9.44M | 0 | 0 | 0 | 1 | 0 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -1,214,136 | -$213.65M | 0 | 0 | 1 | 0 | 2 |
| BEAM | BEAM THERAPEUTICS INC | -1,211,867 | $14.64M | 0 | 0 | 2 | 0 | 2 |
| MCK | MCKESSON CORP | -1,198,758 | -$443.85M | 3 | 1 | 8 | 2 | 12 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | -1,190,100 | -$3.31K | 0 | 0 | 1 | 0 | 2 |
| GSK | GSK PLC-SPON ADR | -1,187,421 | $398.98M | 1 | 3 | 6 | 2 | 10 |
| ACCD | ACCOLADE INC | -1,166,765 | -$22.91M | 0 | 1 | 1 | 0 | 3 |
| AKBA | AKEBIA THERAPEUTICS INC | -1,127,283 | $757 | 0 | 0 | 1 | 0 | 1 |
| KPTI | KARYOPHARM THERAPEUTICS INC | -1,057,577 | -$330 | 0 | 0 | 1 | 0 | 1 |
| ASRT | ASSERTIO HOLDINGS INC | -1,050,555 | -$1.35K | 0 | 0 | 1 | 0 | 1 |
| VERV | VERVE THERAPEUTICS INC | -949,880 | -$17.71M | 0 | 1 | 1 | 0 | 2 |
| AGL | AGILON HEALTH INC | -869,573 | -$20.20M | 1 | 2 | 2 | 0 | 5 |
| MCRB | SERES THERAPEUTICS INC | -817,000 | -$1.14K | 0 | 0 | 0 | 1 | 0 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -752,809 | -$35.64M | 2 | 4 | 4 | 4 | 11 |
| TSHA | TAYSHA GENE THERAPIES INC | -748,900 | $65.20K | 0 | 1 | 1 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | -715,586 | -$114.87M | 1 | 3 | 8 | 2 | 14 |
| NKTR | NEKTAR THERAPEUTICS | -704,794 | $12.71K | 0 | 0 | 1 | 0 | 2 |
| NVS | NOVARTIS AG-SPONSORED ADR | -680,072 | -$132.92M | 1 | 4 | 3 | 1 | 9 |
| INCY | INCYTE CORP | -679,812 | -$157.15M | 3 | 3 | 3 | 1 | 10 |
| SGRY | SURGERY PARTNERS INC | -628,935 | -$31.22M | 1 | 1 | 1 | 0 | 3 |
| GANX | GAIN THERAPEUTICS INC | -584,510 | -$1.92M | 0 | 1 | 0 | 1 | 1 |
| ACHC | ACADIA HEALTHCARE CO INC | -566,963 | -$38.11M | 0 | 2 | 2 | 0 | 4 |
| CAH | CARDINAL HEALTH INC | -565,830 | -$12.84M | 3 | 1 | 6 | 2 | 12 |
| SGMO | SANGAMO THERAPEUTICS INC | -547,901 | $32 | 0 | 0 | 1 | 0 | 1 |
| NUVB | NUVATION BIO INC | -543,426 | $8.07M | 0 | 0 | 1 | 1 | 2 |
| SDGR | SCHRODINGER INC | -534,763 | -$102.76M | 0 | 1 | 1 | 0 | 3 |
| BKD | BROOKDALE SENIOR LIVING INC | -529,224 | $1.10M | 0 | 1 | 1 | 0 | 2 |
| FGEN | FIBROGEN INC | -516,912 | -$215 | 0 | 0 | 1 | 0 | 1 |
| SENS | SENSEONICS HOLDINGS INC | -515,500 | -$309 | 0 | 0 | 1 | 0 | 1 |
| BNGO | BIONANO GENOMICS INC | -514,230 | -$972 | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q1 2024
What are the most sold Healthcare stocks in Q1 2024?
The most sold healthcare stocks in Q1 2024 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2024?
Among filers in this sector, net reductions were largest in companies such as GILEAD SCIENCES INC (GILD), TEVA PHARMACEUTICAL-SP ADR (TEVA), TELADOC HEALTH INC (TDOC), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2023).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.